Breast-milk monitoring to measure Michigan's contamination with polybrominated biphenyls

Polychlorinated biphenyl contamination of nursing mothers' milk in Michigan

The problem of environmental contamination by toxic substances and human exposure to these substances has attracted increased attention in recent years. Particular concern has centered on polychlorinated biphenyls (PCBs), which have become widespread environmental pollutants as well as contaminants of the human population. This paper reports data from a study of PCB contamination of nursing mothers' breast milk in Michigan. During 1977 and 1978, breast milk samples of 1,057 nursing mothers residing in Michigan were tested for PCB residues. All of the 1,057 samples collected from 68 of the state's 83 counties contained PCB residues ranging from trace amounts to 5,100 parts per million (fat weight basis). The mean level was 1,496 parts per million (ppm), with 49.5 per cent of the samples having PCB levels of 1-2 ppm, 17.4 per cent had 2-3 ppm, and 6.14 per cent had more than 3 ppm. There was no consistent trend in the level of PCB contamination over the 24 months of monitoring. The mean PCB level for the eighth quarter of monitoring was slightly higher than for the first quarter. The public health significance of PCB contamination in human populations and its effects on breast-fed for eight months by a woman with the average PCB level in this sample would have an estimated body burden of approximately 0.89 ppm of PCBs. The implications of PCB contamination of human milk with regard to current breast-feeding practices are discussed and several precautionary measures are recommended.

Cohort study of Michigan residents exposed to polybrominated biphenyls: epidemiologic and immunologic findings

Polybrominated biphenyls (PBB) were dispersed widely in Michigan by a 1973 shipping accident in which PBB was introduced into cattle feed. Human exposure resulted principally from ingestion of contaminated dairy food products. To determine whether PBB exposure has or will cause acute or chronic illness, a prospective cohort study of 4545 persons has been undertaken. Three exposure groups were sought; all persons living on PBB-quarantined farms; persons who had received food directly from such farms; workers (and their families) engaged in PBB manufacture. Enrollment rates were 95.6, 95.1 and 78.0%. Also enrolled were 725 persons with low-level PBB exposure. All were queried concerning 17 symptoms and conditions related possibly to PBB. Venous blood was drawn on 3639 and analyzed for PBB by gas chromatography. Mean serum PBB levels were 26.9 ppb in quarantined farm families, 17.1 in recipients, 43.0 ppb in workers, and 3.4 ppb in the low exposure groups. No associations were found between serum PBB levels and symptom prevalence rates. To evaluate peripheral lymphocyte function, T and B cell quantitation and in vitro responses to 3 nonspecific mitogens were studied in 34 persons with highest PBB levels (mean, 787 ppb), and in 56 with low values (mean, 2.8 ppb). No statistically significant differences in lymphocyte number or function were noted.